ASSOCIATION FOR ACCESSIBLE MEDICINES
Sign in to add to a watchlist →
lobbying_client · US · canonical: association accessible medicines · 6 aliases · 3 outbound · 23 inbound
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-18 · lobbied by Greg Barnes · lda_lobbyist_client
- 2026-05-18 · lobbied by Michael Burley · lda_lobbyist_client
- 2026-05-18 · lobbied by John Mason Long · lda_lobbyist_client
- 2026-05-18 · lobbied by Zachary Benjamin Friend · lda_lobbyist_client
- 2026-05-18 · lobbied by Cristina Antelo · lda_lobbyist_client
- 2026-05-18 · lobbied by Michael Taggart · lda_lobbyist_client
- 2026-05-18 · lobbied by Heather Turnbull · lda_lobbyist_client
- 2026-05-18 · lobbied by Katelyn Schultz · lda_lobbyist_client
- 2026-05-18 · lobbied by John Strom · lda_lobbyist_client
- 2026-05-18 · lobbied by Debra Dixon · lda_lobbyist_client
- 2026-05-18 · lobbied by William David Rubin · lda_lobbyist_client
- 2026-05-18 · lobbied by Kara-Marie Urban · lda_lobbyist_client
- 2026-05-18 · lobbied by Mark Williams · lda_lobbyist_client
- 2026-05-18 · lobbied by Everett Eissenstat · lda_lobbyist_client
- 2026-05-18 · lobbied by Joseph H Gibson · lda_lobbyist_client
- 2026-01-01 · lobbied for by FEROX STRATEGIES $40,000 · lda_filing
- 2026-01-01 · lobbied on Preserve Access to Affordable Generics and Biosimilars Act (s. 1096) · lobbying_bill_mention
- 2026-01-01 · lobbied for by TWINLOGIC STRATEGIES, LLP · lda_filing
- 2026-01-01 · lobbied for by SQUIRE PATTON BOGGS $30,000 · lda_filing
- 2026-01-01 · lobbied on Drug Competition Enhancement Act (s. 1040) · lobbying_bill_mention
- 2026-01-01 · lobbied for by FEROX STRATEGIES · lda_filing
- 2026-01-01 · lobbied for by RUBIN, TURNBULL & ASSOCIATES $150,000 · lda_filing
- 2026-01-01 · lobbied for by THE GIBSON GROUP, LLC $60,000 · lda_filing
- 2026-01-01 · lobbied on Affordable Prescriptions for Patients Act (s. 1041) · lobbying_bill_mention
- 2025-01-01 · lobbied for by SQUIRE PATTON BOGGS · lda_filing
- 2025-01-01 · lobbied for by FOLEY & LARDNER LLP · lda_filing
Lobbying disclosures — as CLIENT (9)
Filings where this org hired a lobbying firm. Income + expenses come from the LDA disclosure.
| Posted | Filing | Year | Period | Registrant (lobbying firm) | Income | Expenses |
|---|---|---|---|---|---|---|
| 2026-04-17 | 1st Quarter - Report | 2026 | first_quarter | 401104769 | $40,000 | — |
| 2026-04-17 | 1st Quarter - Report | 2026 | first_quarter | 401106132 | $150,000 | — |
| 2026-04-14 | 1st Quarter - Report | 2026 | first_quarter | 30906 | $30,000 | — |
| 2026-04-09 | 1st Quarter - Report | 2026 | first_quarter | 400703107 | $60,000 | — |
| 2026-03-27 | Registration | 2026 | first_quarter | 401104769 | — | — |
| 2026-03-12 | Registration | 2026 | first_quarter | 400493431 | — | — |
| 2025-04-08 | 1st Quarter - Report | 2025 | first_quarter | 400703107 | $30,000 | — |
| 2025-03-18 | Registration | 2025 | first_quarter | 15042 | — | — |
| 2025-02-19 | Registration | 2025 | first_quarter | 30906 | — | — |
Aliases (6)
| source | id | name at source | jurisdiction | confidence | linked by | linked at |
|---|---|---|---|---|---|---|
| lda_client | 71731 | ASSOCIATION FOR ACCESSIBLE MEDICINES | US | gold | backfill_0029 | |
| lda_client | 64349 | ASSOCIATION FOR ACCESSIBLE MEDICINES | US | gold | backfill_0029 | |
| lda_client | 72007 | ASSOCIATION FOR ACCESSIBLE MEDICINES | US | gold | backfill_0029 | |
| lda_client | 194417 | ASSOCIATION FOR ACCESSIBLE MEDICINES | US | gold | backfill_0029 | |
| lda_client | 70542 | ASSOCIATION FOR ACCESSIBLE MEDICINES | US | gold | backfill_0029 | |
| lda_client | 64990 | ASSOCIATION FOR ACCESSIBLE MEDICINES | US | gold | backfill_0029 |
Outbound edges (3)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | lobbies_on_bill | S 1040 — Drug Competition Enhancement Act | — | S. 1040 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1041 — Affordable Prescriptions for Patients Act | — | S. 1041 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1096 — Preserve Access to Affordable Generics and Biosimilars Act | — | S. 1096 | lobbying_bill_mention |
Inbound edges (23)
| date | from | type | amount | source |
|---|---|---|---|---|
| — | Joseph H Gibson | lobbied_for | — | lda_lobbyist_client |
| — | Everett Eissenstat | lobbied_for | — | lda_lobbyist_client |
| — | Mark Williams | lobbied_for | — | lda_lobbyist_client |
| — | William David Rubin | lobbied_for | — | lda_lobbyist_client |
| — | Kara-Marie Urban | lobbied_for | — | lda_lobbyist_client |
| — | Debra Dixon | lobbied_for | — | lda_lobbyist_client |
| — | John Strom | lobbied_for | — | lda_lobbyist_client |
| — | Katelyn Schultz | lobbied_for | — | lda_lobbyist_client |
| — | Heather Turnbull | lobbied_for | — | lda_lobbyist_client |
| — | Michael Taggart | lobbied_for | — | lda_lobbyist_client |
| — | Cristina Antelo | lobbied_for | — | lda_lobbyist_client |
| — | Zachary Benjamin Friend | lobbied_for | — | lda_lobbyist_client |
| — | John Mason Long | lobbied_for | — | lda_lobbyist_client |
| — | Michael Burley | lobbied_for | — | lda_lobbyist_client |
| — | Greg Barnes | lobbied_for | — | lda_lobbyist_client |
| 2026-01-01 | TWINLOGIC STRATEGIES, LLP | lobbies_for | — | lda_filing |
| 2026-01-01 | FEROX STRATEGIES | lobbies_for | — | lda_filing |
| 2025-01-01 | FOLEY & LARDNER LLP | lobbies_for | — | lda_filing |
| 2025-01-01 | SQUIRE PATTON BOGGS | lobbies_for | — | lda_filing |
| 2026-01-01 | RUBIN, TURNBULL & ASSOCIATES | lobbies_for | $150,000 | lda_filing |
| 2026-01-01 | THE GIBSON GROUP, LLC | lobbies_for | $60,000 | lda_filing |
| 2026-01-01 | FEROX STRATEGIES | lobbies_for | $40,000 | lda_filing |
| 2026-01-01 | SQUIRE PATTON BOGGS | lobbies_for | $30,000 | lda_filing |